Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Quazepam
Drug ID BADD_D01887
Description Quazepam is a drug which is a benzodiazepine derivative. It induces impairment of motor function and has hypnotic properties. Quazepam is used to treat insomnia.
Indications and Usage Used to treat insomnia.
Marketing Status approved; illicit
ATC Code N05CD10
DrugBank ID DB01589
KEGG ID D00457
MeSH ID C025130
PubChem ID 4999
TTD Drug ID D03NPH
NDC Product Code 71993-265; 61825-165; 53883-5783
UNII JF8V0828ZI
Synonyms quazepam | Quiedorm | Doral | Sch 16134 | Sch-16134
Chemical Information
Molecular Formula C17H11ClF4N2S
CAS Registry Number 36735-22-5
SMILES C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Asthenia08.01.01.001---
Depressed level of consciousness17.02.04.002--
Depression19.15.01.001--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Drug withdrawal syndrome08.06.02.004; 19.07.06.013---
Dry mouth07.06.01.002--
Dyspepsia07.01.02.001--
Fatigue08.01.01.002--
Headache17.14.01.001--
Mental disability26.01.01.001---
Somnolence17.02.04.006; 19.02.05.003--
Thinking abnormal17.02.05.023; 19.10.03.001---
Withdrawal syndrome08.06.02.012; 19.07.06.023---
Abnormal behaviour19.01.01.001---
The 1th Page    1    Total 1 Pages